肾脏病学的发展展望论文

参考文献是在药学毕业论文的写作过程中，对某一著作或论文的整体的参考或借鉴，是论文的重要构成部分。下面是我带来的关于的内容，欢迎阅读参考! ***一*** [1] World Health Organization. Men, ageing and health across the life span[J].2001. [2] Rybak MJ. The pharmacokinetic and pharmacodynamic properties of vanycin[J]. Clin InfectDis, 2006,42 Suppl 1: S35-39. [3] 汪复， 朱德妹， 胡付品，等。 2012 年中国 CHINET 细菌耐药性监测[J]. 中国感染与化疗杂志，2013,13***5*** :321-330. [4] Sanchez J, Dominguez A, Lane J, et al. Population pharmacokinetics of vanycin in *** andgeriatric patients: parison of eleven approaches[J]. International journal of clinical pharmacologyand therapeutics, 2010,48***8***： 525-533. [5] 肖永红， 陈佰义， 何礼贤，等。 万古霉素临床应用剂量中国专家共识[J]. 中华传染病杂志，2012,30***11***： 641-646. [6] 陈佰义， 管向东， 何礼贤。 万古霉素临床应用中国专家共识 ***2011 版***[J]. 中国新药与临床杂志， 2011,30 ***8***： 561-573. [7] Anderson RC, Worth HM, Harris PN, et al. Vanycin, a new antibiotic. IV. Pharmacologic andtoxicologic studies[J]. Antibiot Annu, 1956: 75-81. [8]唐勤， 葛卫红， 丁义涛。 万古霉素对肝移植并发腹腔感染的治疗监测及药动学研究[J]. 江苏药学与临床研 究， 2002,10***02***： 4-6. [9] 胡瑾瑜， 施耀国， 张菁，等。 万古霉素在健康老年人和年轻人的药代动力学[J]. 中国抗感染化疗杂志， 2003,3***3***： 138-142. [10] 毕明慧。 老年重症感染患者使用万古霉素的疗效及安全性分析[J]. 北京医学， 2011,33***06***：491-493. ***二*** [1]李红.中医综合疗法对慢性肾衰免疫功能和营养状态的初步探讨[D].广州中医药大学2001 [2]谢国华，蒋慧娟.胶原酶盘内注射治疗腰椎间盘突出症[J].江苏中医.1999***02*** [3]苏国彬.中医综合疗法对非透析慢性肾脏病患者的生存分析[D].广州中医药大学2011 [4]夏芸芸.中医综合疗法治疗血系虚劳***慢性再生障碍性贫血***临床观察[D]. [5]陈向丽.中医综合疗法治疗抑郁症的临床研究[D].广州中医药大学2010 [6]张喜峰.中医综合疗法治疗腰椎间盘突出症***腰痛病***的临床研究[D].长春中医药大学2011 [7]高升.中医综合疗法治疗风痰瘀阴型急性缺血性中风的临床研究[D].广州中医药大学2011 [8]宋铁兵.腰椎间盘突出症三扳手法规范及力学量化研究[D].中国中医科学院2008 [9]刘超.药盐热敷配合补肾中药治疗膝关节骨性关节炎的临床研究[D].广州中医药大学2008 [10]秦丰伟.中医综合疗法和PKP治疗骨质疏松性椎体压缩性骨折的临床疗效对比研究[D].广州中医药大学2014辽宁中医药大学2008 [11]卓金锁.中医综合疗法治疗膝骨性关节炎的临床研究[D].北京中医药大学2007 [12]苗林.中医综合疗法配合玻璃酸钠关节腔注射治疗膝关节骨性关节炎的临床研究[D].湖北中医药大学2013 [13]高翔，李加坤.胶原酶注射治疗腰椎间盘突出症[J].中国厂矿医学.1999***01*** [14]孙磊，宁志杰，王培杰，廖可国，李瑞生，王培文.胶原酶椎间盘内注射后的形态观察[J].中国矫形外科杂志.1997***05*** [15]张昌颖主编.生物化学[M].人民卫生出版社，1985 ***三*** [1]陈嘉聪.老年全髋关节置换术后早期中医证候调查[D].广州中医药大学2008 [2]胡永波.利腰颗粒治疗腰椎间盘突出症急性期***溼热型***的疗效研究及免疫学分析[D].广州中医药大学2008 [3]王功国.消肿止痛纱治疗尺桡骨骨折所致前臂肿胀疼痛的临床研究[D].青岛大学2014 [4]刘弋详.踝关节扭伤***慢性踝关节不稳***中医治疗方案临床疗效观察[D].成都中医药大学2014 [5]邓祎.中医治疗膝关节半月板损伤的临床疗效观察[D].成都中医药大学2014 [6]王开强.关节镜清理术、股四头肌训练、中药薰蒸治疗膝OA的临床研究[D].成都中医药大学2014 [7]黄翊峰.痛点封闭联合针刺治疗肩周炎急性期的临床疗效观察[D].成都中医药大学2014 [8]杨艳.阿是穴四花刺治疗膝骨关节炎疼痛的临床观察[D].成都中医药大学2014 [9]乔浩.膝关节僵硬中医康复方案临床疗效观察[D].成都中医药大学2014 [10]张婷.子午流注择时穴位敷贴在膝关节骨性关节炎中的应用研究[D].成都中医药大学2014 [11]郑文进.电针配合推拿手法治疗血瘀型腰椎间盘突出症的临床研究[D].广州中医药大学2008 [12]李源.腰椎间盘突出症中医血瘀证患者的颈椎间盘退变研究[D].湖北中医学院2008 [13]陈德元.身痛逐瘀汤加减对腰椎间盘突出症术后麻木治疗[D].广州中医药大学2011 [14]江共群.骨洗2方薰蒸预防腰椎间盘突出症术后残留痛的临床观察[D].广州中医药大学2010 [15]***.独活寄生汤联合PKP治疗老年骨质疏松性胸腰椎压缩骨折疗效观察[D].成都中医药大学2014

Xie Y, Nishi S, Iguchi S, Imai N, Sakatsume M, Saito A, Ikegame M, Iino N, Shimada H, Ueno M, Kawashima H, Arakawa M, and Gejyo F. Expression of osteopontin in gentamicin-induced acute tubular necrosis and its recovery process. Kidney Int. 2001; 59(3): 959-974. Xie Y, Sakatsume M, Nishi S, Narita I, Arakawa M, and Gejyo F. Expression, roles, receptors, and regulation of osteopontin in the kidney. Kidney Int. 2001; 60(5): 1645-1657. Sakatsume M, Xie Y, Ueno M, Obayashi H, Goto S, Narita I, Homma N, Tasaki K，Suzuki Y, and Gejyo F. Human glomerulonephritis accompanied by active cellular infiltrates shows effector T cells in urine. J Am Soc Nephrol. 2001; 12(12): 2636-2644. Kaneko Y, Sakatsume M, Xie Y, Kuroda T, Igashima M, Narita I, Gejyo F. Macrophage metalloelastase as a major factor for glomerular injury in anti-glomerular basement membrane nephritis. J Immunol. 2003; 170(6): 3377-3385. Xie Y, Nishi S, Ueno M, Imai N, Sakatsume M, Narita I, Suzuki Y, Akazawa K, Shimada H, Arakawa M, Gejyo F. The efficacy of tonsillectomy on long-term renal survival in patients with IgA nephropathy. Kidney Int. 2003; 63(5): 1861-1867. Xie Y, Chen X, Nishi S, Narita I, Gejyo F. Relationship between tonsils and IgA nephropathy as well as indications of tonsillectomy. Kidney Int 2004; 65(4): 1135-1144. Xie Y, Nishi S, Fukase S, Nakamura H, Chen X, Imai N, Sakatsume M, Saito A, Ueno M, Narita I, Yamamoto T, and Gejyo F. Different type and localization of CD44 on surface membrane of regenerative renal tubular epithelial cells in vivo. Am J Nephrol. 2004; 24(2): 188-197. Wu J, Chen X, Xie Y, Yamanaka N, Shi S, Wu D, Liu S, and Cai G. Characteristics and risk factors of intrarenal arterial lesions in patients with IgA nephropathy. Nephrol Dial Transpl. 2005; 20(4): 719-727. Jiang H, Zhu H, Chen X, Peng Y, Wang J, Liu F, Shi S, Fu B, Lu Y, Hong Q, Feng Z, Hou K, Sun X, Cai G, Zhang X, Xie Y. TIMP-1 Transgenic Mice Recover From Diabetes Induced by Multiple Low-Dose Streptozotocin. Diabetes. 2007; 56(1): 49-56. Xie Y, Chen X. Epidemiology, major outcomes, risk factors, prevention and management of chronic kidney disease in China. Am J Nephrol. 2008; 28（1）：1-7. Tu X, Chen X, Xie Y, Shi S, Wang J, Chen Y, Li J. Anti-inflammatory renoprotective effect of clopidogrel and irbesartan in chronic renal injury. J Am Soc Nephrol. 2008; 19(1): 77-83. Zhou J, Chen X, Xie Y, Li J, Yamanaka N, Tong X. A Differential Diagnostic Model of Diabetic Nephropathy and Non-Diabetic Renal Diseases. Nephrol Dial Transplant. 2008; 23(6):1940-1945. Liu S, Xie Y, Lv Y, Qin F, Fu B, Shi S, Yin Z, Hong Q, Zhang X, Wang J, Chang M, Chen X. A Novel Target of Mizoribine Inhibiting Mesangial Cell Proliferation: S Phase Kinase-Associated Protein 2. Am J Nephrol. 2010; 32(5): 447-455. Liu X, Lv Y, Xie Y, Hong Q, Cai G, Zhang S, Liu W, Chen X. Change of MAX Interactor 1 Expression in an Anti-Thy1 Nephritis Model and its Effect on Mesangial Cell Proliferation. Cell Physiol Biochem. 2011; 27(3-4): 391-400. Xie Y, Huang S, Wang L, Miao L, Zhang A, Li Y, Wu X, Wang L, Liu S, Lie C, Chen P, Chen X. The efficacy and safety of mizoribine combined with losartan in the treatment of IgA nephropathy: A multicenter, randomized, controlled study. Am J Med Sci. 2011; 341(5): 367-372. Lu Z, Xie Y, Liu X, Cui S, Wu Y, Cai C, Zhang L, Chen X. Effect of 5/6 Nephrectomized Rat Serum on Epithelial-to-Mesenchymal Transition In Vitro. Ren Fail. 2011; 33 (6): 600-608. Wang W, Lv N, Zhang S, Shui G, Qian H, Zhang J, Chen Y, Ye J, Xie Y, Shen Y, Wenk MR, Li P. Cidea is an essential transcriptional coactivator regulating mammary gland secretion of milk lipids. Nat Med. 2012; 18(2): 235-243. Lu Y, Liu X, Shi S, Su H, Bai X, Cai G, Yang F, Xie Z, Zhu Y, Zhang Y, Zhang S, Li X, Wang S, Wu D, Zhang L, Wu J, Xie Y, Chen X. Bioinformatics analysis of proteomic profiles during the process of anti-Thy1 nephritis. Mol Cell Proteomics. 2012;11(4):. 19. Ji J, Li Q, Xie Y, Zhang X, Cui S, Shi S, Chen X. Overexpression of Robo2 causes defects in the recruitment of metanephric mesenchymal cells and ureteric bud branching morphogenesis. Biochem Biophys Res Commun. 2012; 421(3): 494-500. Hong Q, Li C, Xie Y, Lv Y, Liu X, Shi S, Ding R, Zhang X, Zhang L, Liu S, Chen X. Kruppel-like Factor-15 Inhibits the Proliferation of Mesangial Cells. Cell Physiol Biochem. 2012;29(5-6):893-904. Hu J, Zhang L, Wang N, Ding R, Cui S, Zhu F, Xie Y, Sun X, Wu D, Hong Q, Li Q, Shi S, Liu X, Chen X. Mesenchymal stem cells attenuate ischemic acute kidney injury by inducing regulatory T cells through splenocyte interactions. Kidney Int. 2013;84(3):521-531. Lu ZY, Liu SW, Xie YS, Cui SY, Liu XS, Geng WJ, Hu X, Ji JY, and Chen XM. Inhibition of the Tubular Epithelial-to-Mesenchymal Transition in vivo and in vitro by the Uremic Clearance Granule. Chin J Integr Med. 2013;19(12): 918-926. Jin M, Zhu S, Hu P, Liu D, Li Q, Li Z, Zhang X, Xie Y, Chen X. Genomic and epigenomic analyses of monozygotic twins discordant for congenital renal agenesis. Am J Kidney Dis. 2014;64(1):119-122. Wang X, Tao T, Ding R, Song D, Liu M, Xie Y, Liu X. Kidney Protection against Ischemia/Reperfusion Injury by Myofibrillogenesis Regulator-1. Am J Nephrol. 2014;39(4):279-287. Jin M, Hu P, Ding R, Chen P, Qiu Q, Wu J, Liu S, Xie Y, Chen X. Effectiveness of supine/standing urinalysis for differential diagnosis of left renal vein entrapment syndrome combined with or without glomerulopathy. Nephrology (Carlton). 2014;19(6):332-338 Jin M, Xie Y, Li Q, Chen X. Stem Cell-Based Cell Therapy for Glomerulonephritis. Biomed Res Int. 2014;2014:124730. Hu P, Jin M, Xie Y, Chen P, Zhang X, Yin Z, Cai G, Chen X. Immunoglobulin A nephropathy in horseshoe kidney: case reports and literature review. Nephrology (Carlton). 2014;19(10):605-609. Yang Y, Xie Y, Wang C, Chen G, Kong D, Zhou Z, Wang Y, Qi K, Song M, Ma L. Establishing Equations to Evaluate 24-Hour Urine Protein Excretion Using Routine Urinalysis. Nephrology (Carlton). 2014;19(11):685-692. 谢院生, 陈香美. 扁桃体与IgA肾病的发病和治疗. 中华肾脏病杂志 2004，20（4）：300-302. 谢院生, 陈香美. 急性肾小管坏死后的修复与再生. 中华肾脏病杂志, 2006; 22(11): 658-660. 谢院生. 咪唑立宾在肾脏病中的应用. 中国中西医结合肾病杂志. 2008，9（7）：565-568. 谢院生. 地震挤压伤导致急性肾衰竭的救治. 武警医学. 2008, 19（10）：869-872. 谢院生，陈香美. 加深对横纹肌溶解症的认识. 军医进修学院学报. 2008, 29(6): 447-448. 谢院生，刘晓峦，陈香美. 运动性横纹肌溶解症的诊治. 军医进修学院学报. 2008, 29(6): 449-452. 谢院生，刘晓峦，陈香美. 横纹肌溶解致急性肾损伤的诊治. 中国血液净化.2009，8（3）：120-123. 谢院生，周建辉，陈香美. 糖尿病肾病早期诊断与防治. 北京医学. 2009，31（3）：173-175. 谢院生，陈香美. IgA肾病病情评估及预后判断的无创生物标志物. 中国中西医结合肾病杂志. 2010；11（5）：377-380. 谢院生，刘晓峦，陈香美. 胚肾发育相关的生长因子在急性肾损伤修复再生中的作用. 武警医学. 2011, 22（7）：553-556. 谢院生, 刘玉宁. 糖尿病肾病的诊断与中西医结合治疗[J/CD]. 中华肾病研究电子杂志. 2013; 2(4): 168-172. 谢院生，齐焰，章友康. 慢性肾脏病的脂质管理及非他汀类调脂药的临床应用. 中国医院用药评价与分析. 2014；14（5）：387-389.